| Primary |
| Product Used For Unknown Indication |
100.0% |
|
|
| Secondary |
| Hepatitis C |
13.9% |
| Product Used For Unknown Indication |
12.9% |
| Chronic Hepatitis C |
10.9% |
| Hypertension |
7.9% |
| Prophylaxis |
5.9% |
| Carcinoma Hepatocellular |
5.0% |
| Concomitant Disease Progression |
5.0% |
| Hepatitis B |
5.0% |
| Anxiety |
4.0% |
| Cholelithiasis |
4.0% |
| Drug Use For Unknown Indication |
4.0% |
| Chronic Hepatitis |
3.0% |
| Epilepsy |
3.0% |
| Liver Disorder |
3.0% |
| Rheumatoid Arthritis |
3.0% |
| Ascites |
2.0% |
| Asthma |
2.0% |
| Cholecystitis |
2.0% |
| Dementia |
2.0% |
| Gastric Ulcer |
2.0% |
|
| Hepatic Function Abnormal |
8.3% |
| Pruritus |
8.3% |
| Scab |
8.3% |
| White Blood Cell Count Decreased |
8.3% |
| Amylase Increased |
4.2% |
| Dermatitis Exfoliative |
4.2% |
| Eczema Asteatotic |
4.2% |
| Eosinophil Count Increased |
4.2% |
| Facial Palsy |
4.2% |
| Generalised Erythema |
4.2% |
| Hepatic Encephalopathy |
4.2% |
| Liver Disorder |
4.2% |
| Neuroleptic Malignant Syndrome |
4.2% |
| Pneumocystis Jiroveci Pneumonia |
4.2% |
| Pneumonia |
4.2% |
| Pyrexia |
4.2% |
| Rash Papular |
4.2% |
| Renal Impairment |
4.2% |
| Shock |
4.2% |
| Skin Ulcer |
4.2% |
|
| Concomitant |
| Chronic Hepatitis C |
31.4% |
| Prophylaxis |
13.5% |
| Hepatitis C |
9.0% |
| Hypertension |
8.8% |
| Product Used For Unknown Indication |
5.0% |
| Rheumatoid Arthritis |
4.4% |
| Drug Use For Unknown Indication |
4.4% |
| Hepatic Cirrhosis |
2.8% |
| Hiv Infection |
2.7% |
| Insomnia |
2.7% |
| Diabetes Mellitus |
2.5% |
| Gastritis |
2.1% |
| Infection Prophylaxis |
2.0% |
| Constipation |
1.7% |
| Hyperuricaemia |
1.3% |
| Hepatocellular Carcinoma |
1.2% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Liver Disorder |
1.1% |
| Osteoporosis |
1.1% |
| Depression |
1.1% |
|
| White Blood Cell Count Decreased |
18.4% |
| Renal Impairment |
12.1% |
| Rash |
7.7% |
| Pyrexia |
7.4% |
| Vomiting |
5.1% |
| Liver Disorder |
4.6% |
| Neutrophil Count Decreased |
4.2% |
| Interstitial Lung Disease |
3.9% |
| Platelet Count Decreased |
3.9% |
| Sepsis |
3.9% |
| Renal Disorder |
3.4% |
| Retinopathy |
3.4% |
| Drug Eruption |
3.2% |
| White Blood Cell Count Increased |
3.1% |
| Haemoglobin Decreased |
2.8% |
| Hepatic Function Abnormal |
2.8% |
| Rhabdomyolysis |
2.8% |
| Renal Failure Acute |
2.6% |
| Malaise |
2.5% |
| Hyperuricaemia |
2.3% |
|
